Answers are grounded in this paper and cite their sources.
WIREs Systems Biology and Medicine was founded on the emergence of next-generation technologies that offered unprecedented ability to make multi-scale measurements on living systems, which in turn enabled developing systems perspectives on mechanisms governing function. Nextgen sequencing and related technologies provided profound insights into genomic, transcriptomic, epigenomic and other omics-driven mechanisms. Over the decade of its existence WIREs Systems Biology and Medicine has published reviews from detailed systems level views of microbes to humans highlighting new techniques and sophisticated models of complex systems. The most significant outcome of the Journal has been reviews that provide detailed insights into mechanisms of normal and aberrant function presented at multiple scales and levels of granularity. We described in an Editorial in our first issue of the Journal that our goal was to bring together experimental biologists, physiologists, computational and data modelers and innovators and practitioners of new technology together to pose questions at the systems level in qualitative and quantitative detail that was hitherto not feasible (Nadeau & Subramaniam, 2009). At the beginning of the 21st century, systems, data, and engineering perspectives began to be applied to biological systems, largely cells, from microbes to mammals. The major thrust of systems biology was regarded as developing experimentally validated network and analytical models of cellular functions using high-throughput measurements and the largesse of emergent data. The hope of these attempts was ultimately to model human physiology and pathophysiology at multiple scales to understand human health. Systems Biology was the harbinger for Systems Medicine, which transcends cellular function to describe tissues, organs, and systems physiology. The successes of the WIREs Systems Biology and Medicine reviews are best summarized by the key phrase, these reviews provide insights into complex mechanisms and offer the potential to scale these mechanisms from few molecular functions to large cellular networks and to complex interactions in tissues, organs and physiology. With the focus on mechanisms, it is natural to rechristen the journal to WIREs Mechanisms of Disease. With the exceptional popularity of genome sequencing companies like “23andMe” or “Ancestry”, there is increasing recognition on how genes determine traits, and in some instances, lead to pathophysiology. More high resolution genome sequencing of humans, heralded by efforts like 10K and 100K genomes, have gone further in linking in specific cases genetic mutations that result in aberrant function. The mutations in BRCA1 associated with breast cancer and those in presenilin proteins that lead to familial Alzheimer's disease are exemplars. While there is progress in population-level association of gene mutations leading to diseases, as highlighted by the National Institutes of Health resource, “On Mendelian Inheritance in Man (OMIM)”, it still begs the question of mechanisms associated with the mutations that lead to dysfunction. How do mutations as simple as a single nucleotide substitution in a single gene lead to complex multi-system dysfunctions? Conditions like cystic fibrosis and Huntington's disease reveal Mendelian inheritance patterns that reflect the nature of the underlying gene (Jorde, Little, Dunn, & Subramaniam, 2004 ). In clinical genetics, there are several diseases diagnosed to have strong genetic component and show familial recurrence but show no clear Mendelian inheritance. An interesting example is holoprosencephaly characterized by incomplete separation of the forebrain into distinct halves, showing familial recurrence. Several causative genes such as SHH, ZIC2, SIX3 and TGIF are suspected to be involved suggesting gene–gene interactions (Nanni et al., 1999). There are also genetic modifier effects, an exceedingly common finding whose mechanisms are mostly undefined. Hereditary haemochromatosis, tissue damage resulting from excessive iron storage, is found in individuals homozygous or compound heterozygous for two genetic variants C282Y and H63D of the MHC-linked protein HFE, but the penetrance of these mutations is low in premenopausal women (Merryweather-Clarke et al., 2003). Genome-wide association studies (GWAS) facilitated now by complete genome sequencing has the potential to provide insights into mechanistic implications of these complex mutations-driven traits and this would be a focus of the Journal. Waddington stated in 1950s that “an epigenetic trait is a stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence”. However, what has emerged over the decades is that the epigenetic trait does not have to be inherited, and can be caused by modifications of DNA, DNA-binding proteins, and histones driven largely by “perturbations” that may have no inheritance origin. These epigenetic changes arise somatically, sometimes leading to aberrant phenotypes that emerge during development or over a lifetime. DNA methylation and histone modifications have been implicated in autoimmune diseases (Mazzone et al., 2019) and non-coding RNAs like lncRNA are known to play significant roles in diseases (Miao et al., 2018). While epigenetic origins of diseases are being increasingly discovered, there is a paucity of detailed mechanistic understanding of the alterations in genetic and epigenetic regulatory networks (Feinberg, 2018). Alterations in chromatin topology originating from genetic and epigenetic changes have been attributed to cause debilitating diseases like Alzheimer's disease (Caldwell et al., 2020). With the advent of new sequencing methods such as ATAC-seq, ChIP-seq and Hi-C integrative ‘omics analysis has the potential to provide mechanistic insights into role of epigenetics in origin and progression of human diseases. Another source of developmental differences can be attributed to nonlinear epigenetic processes that can cause somatic variability at phenotypic and behavioral levels (Molenaar, Boomsma, & Dolan, 1993). Non-Mendelian on/off mechanisms, an intriguing concept that leads to bi-stable epigenetic obesity also has significant implications for complex traits (Dalgaard et al., 2016). Development is an important axis of biology, where the formation of tissues and organs are orchestrated with high precision. Several adult conditions originate during development, even when there are no direct associations with genetic changes. Autism Spectrum Disorders and biliary atresia are classic examples of developmental disorders that have no known genetic origins but can have functional changes involving multiple genes and their altered roles in development. In most developmentally associated disorders, detailed mechanisms are seldom known, given lack of access to tissues from human subjects and the inadequacy of animal models in mimicking human development. The revolutionary developments in stem cell biology and CRISPR-based perturbation methods are now at the cusp of providing a fundamental mechanistic understanding of human development. It has become relatively easy to reprogram almost any cell in the human body into induced pluripotent stem cells that in turn can yield any cell type given the right cues and growth factors. Even factors like microRNAs have been used to induce human cardiomyocyte proliferation from induced pluripotent stem cells (Diez-Cuñado et al., 2018). Using bio-mimetic cardiac tissue chips, researchers have reproduced cardiovascular diseases paving the way for precision therapeutic interventions (Rogers et al., 2019). The ability to create organs on a chip or build complex organoids is opening new vistas in mechanistic developmental biology. Human physiology is shaped significantly by the “environmental factors” ranging from diet and lifestyle to the local geo-ecological niche. Despite the exceptional richness of the factors that can influence physiology, adaptation to the factors have relied on core mechanisms and there are substantial studies on human response phenotypes. The most prevalent mechanistic studies include metabolic syndrome associated with insulin resistance (Sears et al., 2009) and obesity and fatty liver diseases (Gorden et al., 2015), both associated with diet and lifestyle with arguably genetic predisposition. Infection also induces a complex interplay between genetic and lifestyle risk factors leading to complex mechanisms (Anca, Toth, Kempler, & Rizzo, 2020; Mukund, Mathee, & Subramaniam, 2020). There can also be a genetic control of phenotypic variation in complex traits (Wang et al., 2019; Yang et al., 2012). Cancer, where somatic mutation landscape, has been extensively studied traces development and progression to non-genetic factors [Cancer at Nature Research Collection 2020]. However, precise mechanisms of how the environment shapes the somatic mutation landscape continues to be a large subject of study (Friedmann-Morvinski, Bhargava, Gupta, Verma, & Subramaniam, 2016). One of the most impactful research areas concerning the environment is study of human microbiome which is sensitive to a host of environmental factors (Badal et al., 2019). The emergent technologies that have enormous potential to measure the microbiome and the metabolome will change the landscape of our understanding human physiology and pathology. Changes in microbial profiles and functionality are a consequence of diet and living environment and the metabolites are end-points of human physiological function. Measurements of these provides the potential to backtrack mechanisms and perhaps the origins of altered physiological function (Mars et al., 2020). Measurements of multiple components of human physiology at unprecedented scales offers unique opportunities to obtain multi-scale mechanisms with spatiotemporal relevance. Cells and tissues integrate genetic, transcriptomic, proteomic, metabolomic and environmental responses to define phenotypes and end-fates. Our ability to integrate these vast data across multiple scales and granularities and across time will eventually pave the way for a comprehensive roadmap for disease mechanisms. This is the holy grail in modern biomedicine and will form the scope of the redefined WIREs Mechanisms of Disease. Diseases of various human organs such as the heart, the brain, the kidney, the lung and others and systemic diseases like immune, vascular and metabolic disorders are ripe for in-depth mechanistic investigations and the outcome of these will be ideal targets for the transformed journal.
No takes yet. Share an insight, caveat, or question.
Subramaniam et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: